These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28561706)

  • 21. Advances in the molecular genetics of gliomas - implications for classification and therapy.
    Reifenberger G; Wirsching HG; Knobbe-Thomsen CB; Weller M
    Nat Rev Clin Oncol; 2017 Jul; 14(7):434-452. PubMed ID: 28031556
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Improved grading of IDH-mutated astrocytic gliomas.
    Pirozzi CJ; Yan H
    Nat Rev Neurol; 2018 Jul; 14(7):383-384. PubMed ID: 29855600
    [No Abstract]   [Full Text] [Related]  

  • 23. The 2016 revision of the WHO Classification of Central Nervous System Tumours: retrospective application to a cohort of diffuse gliomas.
    Rogers TW; Toor G; Drummond K; Love C; Field K; Asher R; Tsui A; Buckland M; Gonzales M
    J Neurooncol; 2018 Mar; 137(1):181-189. PubMed ID: 29218432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Shedding Light on the 2016 World Health Organization Classification of Tumors of the Central Nervous System in the Era of Radiomics and Radiogenomics.
    Colen RR; Hassan I; Elshafeey N; Zinn PO
    Magn Reson Imaging Clin N Am; 2016 Nov; 24(4):741-749. PubMed ID: 27742114
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA methylation signatures for 2016 WHO classification subtypes of diffuse gliomas.
    Paul Y; Mondal B; Patil V; Somasundaram K
    Clin Epigenetics; 2017; 9():32. PubMed ID: 28392842
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 2016 WHO classification of central nervous system tumors: what neurologists need to know.
    DeWitt JC; Mock A; Louis DN
    Curr Opin Neurol; 2017 Dec; 30(6):643-649. PubMed ID: 28901970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Journal of Neuro Oncology: Diagnostic and therapeutic implications of IDH mutations in gliomas following the 2021 World Health Organization classification of CNS tumors.
    Juratli TA; Jungk C; Miller JJ
    J Neurooncol; 2023 May; 162(3):457-459. PubMed ID: 37212938
    [No Abstract]   [Full Text] [Related]  

  • 28. Building diagnoses with four layers: WHO 2016 classification of CNS tumors.
    Bielle F
    Rev Neurol (Paris); 2016; 172(4-5):253-5. PubMed ID: 27210026
    [No Abstract]   [Full Text] [Related]  

  • 29. IDH mutation status in prostate cancer.
    Ghiam AF; Cairns RA; Thoms J; Dal Pra A; Ahmed O; Meng A; Mak TW; Bristow RG
    Oncogene; 2012 Aug; 31(33):3826. PubMed ID: 22120718
    [No Abstract]   [Full Text] [Related]  

  • 30. IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.
    Darlix A; Deverdun J; Menjot de Champfleur N; Castan F; Zouaoui S; Rigau V; Fabbro M; Yordanova Y; Le Bars E; Bauchet L; Gozé C; Duffau H
    J Neurooncol; 2017 May; 133(1):37-45. PubMed ID: 28434111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2007 WHO classification of tumors of the central nervous system - what has changed?
    Rousseau A; Mokhtari K; Duyckaerts C
    Curr Opin Neurol; 2008 Dec; 21(6):720-7. PubMed ID: 18989119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating Genomics Into Neuro-Oncology Clinical Trials and Practice.
    Galanis E; Nassiri F; Coy S; Nejad R; Zadeh G; Santagata S
    Am Soc Clin Oncol Educ Book; 2018 May; 38():148-157. PubMed ID: 30231374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diffuse gliomas to date and beyond 2016 WHO Classification of Tumours of the Central Nervous System.
    Onizuka H; Masui K; Komori T
    Int J Clin Oncol; 2020 Jun; 25(6):997-1003. PubMed ID: 32468200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics.
    Velázquez Vega JE; Brat DJ
    Adv Anat Pathol; 2018 May; 25(3):143-171. PubMed ID: 29521646
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2016 World Health Organization Classification of Central Nervous System Tumors.
    Wen PY; Huse JT
    Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1531-1547. PubMed ID: 29200109
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Revised WHO Classification of Tumours of the Central Nervous System:Summary of the Revision and Perspective].
    Komori T; Sasaki H; Yoshida K
    No Shinkei Geka; 2016 Aug; 44(8):625-35. PubMed ID: 27506840
    [No Abstract]   [Full Text] [Related]  

  • 38. The 2016 World Health Organization classification of tumours of the central nervous system.
    Villa C; Miquel C; Mosses D; Bernier M; Di Stefano AL
    Presse Med; 2018; 47(11-12 Pt 2):e187-e200. PubMed ID: 30449638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WES data from 286 diffuse gliomas under the 2021 WHO Classification of Tumors of the Central Nervous System.
    Zhao Z; Zhang KN; Sun Z; Yang C; Wang Q; Li G; Wang Z; Zeng F; Chai R; Qian Z; Wang Z; Liu Y; Ma W; Wu F; Jiang T
    Sci Data; 2022 Nov; 9(1):692. PubMed ID: 36369198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Understanding the Revised Fourth Edition of the World Health Organization Classification of Tumours of the Central Nervous System (2016) for Clinical Decision-making: A Guide for Oncologists Managing Patients with Glioma.
    Back M; Rodriguez M; Jayamanne D; Khasraw M; Lee A; Wheeler H
    Clin Oncol (R Coll Radiol); 2018 Sep; 30(9):556-562. PubMed ID: 29980381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.